Skip to main content
Erschienen in: Acta Neuropathologica 2/2013

01.08.2013 | Original Paper

Long-duration epilepsy affects cell morphology and glutamatergic synapses in type IIB focal cortical dysplasia

verfasst von: Adele Finardi, Francesca Colciaghi, Laura Castana, Denise Locatelli, Carlo Efisio Marras, Paola Nobili, Maddalena Fratelli, Manuela Adele Bramerio, Giorgio LoRusso, Giorgio Stefano Battaglia

Erschienen in: Acta Neuropathologica | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

To investigate hypothesized effects of severe epilepsy on malformed cortex, we analyzed surgical samples from eight patients with type IIB focal cortical dysplasia (FCD) in comparison with samples from nine non-dysplastic controls. We investigated, using stereological quantification methods, where appropriate, dysplastic neurons, neuronal density, balloon cells, glia, glutamatergic synaptic input, and the expression of N-methyl-d-aspartate (NMDA) receptor subunits and associated membrane-associated guanylate kinase (MAGUK). In all FCD patients, the dysplastic areas giving rise to epileptic discharges were characterized by larger dysmorphic neurons, reduced neuronal density, and increased glutamatergic inputs, compared to adjacent areas with normal cytology. The duration of epilepsy was found to correlate directly (a) with dysmorphic neuron size, (b) reduced neuronal cell density, and (c) extent of reactive gliosis in epileptogenic/dysplastic areas. Consistent with increased glutamatergic input, western blot revealed that NMDA regulatory subunits and related MAGUK proteins were up-regulated in epileptogenic/dysplastic areas of all FCD patients examined. Taken together, these results support the hypothesis that epilepsy itself alters morphology—and probably also function—in the malformed epileptic brain. They also suggest that glutamate/NMDA/MAGUK dysregulation might be the intracellular trigger that modifies brain morphology and induces cell death.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Aarts MM, Tymianski M (2004) Molecular mechanisms underlying specificity of excitotoxic signaling in neurons. Curr Mol Med 4:137–147PubMedCrossRef Aarts MM, Tymianski M (2004) Molecular mechanisms underlying specificity of excitotoxic signaling in neurons. Curr Mol Med 4:137–147PubMedCrossRef
2.
Zurück zum Zitat Alonso-Nanclares L, De Felipe J (2005) Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex. Neuroscience 134:59–68PubMedCrossRef Alonso-Nanclares L, De Felipe J (2005) Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex. Neuroscience 134:59–68PubMedCrossRef
3.
Zurück zum Zitat Alonso-Nanclares L, Garbelli R, Sola RG et al (2005) Microanatomy of the dysplastic neocortex from epileptic patients. Brain 128:158–173PubMedCrossRef Alonso-Nanclares L, Garbelli R, Sola RG et al (2005) Microanatomy of the dysplastic neocortex from epileptic patients. Brain 128:158–173PubMedCrossRef
4.
Zurück zum Zitat Andres M, Andre VM, Nguyen S et al (2005) Human cortical dysplasia and epilepsy: an ontogenetic hypothesis based on volumetric MRI and NeuN neuronal density and size measurements. Cereb Cortex 15:194–210PubMedCrossRef Andres M, Andre VM, Nguyen S et al (2005) Human cortical dysplasia and epilepsy: an ontogenetic hypothesis based on volumetric MRI and NeuN neuronal density and size measurements. Cereb Cortex 15:194–210PubMedCrossRef
5.
Zurück zum Zitat Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB (2012) A developmental and genetic classification for malformations of cortical development: update. Brain 135:1348–1369PubMedCrossRef Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB (2012) A developmental and genetic classification for malformations of cortical development: update. Brain 135:1348–1369PubMedCrossRef
6.
Zurück zum Zitat Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB (2001) Classification system for malformations of cortical development: update 2001. Neurology 57:2168–2178PubMedCrossRef Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB (2001) Classification system for malformations of cortical development: update 2001. Neurology 57:2168–2178PubMedCrossRef
7.
Zurück zum Zitat Battaglia G, Arcelli P, Granata T et al (1996) Neuronal migration disorders and epilepsy: a morphological analysis of three surgically treated patients. Epilepsy Res 26:49–58PubMedCrossRef Battaglia G, Arcelli P, Granata T et al (1996) Neuronal migration disorders and epilepsy: a morphological analysis of three surgically treated patients. Epilepsy Res 26:49–58PubMedCrossRef
8.
Zurück zum Zitat Baybis M, Yu J, Lee A et al (2004) mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 56:478–487PubMedCrossRef Baybis M, Yu J, Lee A et al (2004) mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 56:478–487PubMedCrossRef
9.
Zurück zum Zitat Becker AJ, Urbach H, Scheffler B et al (2002) Focal cortical dysplasia of Taylor’s balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 52:29–37PubMedCrossRef Becker AJ, Urbach H, Scheffler B et al (2002) Focal cortical dysplasia of Taylor’s balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 52:29–37PubMedCrossRef
10.
Zurück zum Zitat Blümcke I, Thom M, Aronica E et al (2011) The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia 52:158–174PubMedCrossRef Blümcke I, Thom M, Aronica E et al (2011) The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia 52:158–174PubMedCrossRef
11.
Zurück zum Zitat Bothwell S, Meredith GE, Phillips J et al (2001) Neuronal hypertrophy in the neocortex of patients with temporal lobe epilepsy. J Neurosci 21:4789–4800PubMed Bothwell S, Meredith GE, Phillips J et al (2001) Neuronal hypertrophy in the neocortex of patients with temporal lobe epilepsy. J Neurosci 21:4789–4800PubMed
12.
Zurück zum Zitat Chamberlain WA, Prayson RA (2008) Focal cortical dysplasia type II (malformations of cortical development) aberrantly expresses apoptotic proteins. Appl Immunohistochem Mol Morphol 16:471–476PubMedCrossRef Chamberlain WA, Prayson RA (2008) Focal cortical dysplasia type II (malformations of cortical development) aberrantly expresses apoptotic proteins. Appl Immunohistochem Mol Morphol 16:471–476PubMedCrossRef
13.
Zurück zum Zitat Colciaghi F, Finardi A, Frasca A et al (2011) Status epilepticus-induced pathologic plasticity in a rat model of focal cortical dysplasia. Brain 134:2828–2843PubMedCrossRef Colciaghi F, Finardi A, Frasca A et al (2011) Status epilepticus-induced pathologic plasticity in a rat model of focal cortical dysplasia. Brain 134:2828–2843PubMedCrossRef
14.
Zurück zum Zitat Crino PB, Duhaime AC, Baltuch G, White R (2001) Differential expression of glutamate and GABA-A receptor subunit m-RNA in cortical dysplasia. Neurology 56:906–913PubMedCrossRef Crino PB, Duhaime AC, Baltuch G, White R (2001) Differential expression of glutamate and GABA-A receptor subunit m-RNA in cortical dysplasia. Neurology 56:906–913PubMedCrossRef
15.
Zurück zum Zitat da Silva AV, Houzel JC, Targas Yacubian EM et al (2006) Dysmorphic neurons in patients with temporal lobe epilepsy. Brain Res 1072:200–207PubMedCrossRef da Silva AV, Houzel JC, Targas Yacubian EM et al (2006) Dysmorphic neurons in patients with temporal lobe epilepsy. Brain Res 1072:200–207PubMedCrossRef
16.
Zurück zum Zitat Engel J Jr, Van Ness PC, Rasmussen TB (1993) Outcome with respect to epileptic seizures. In: J Engel Jr (ed) Surgical treatment of the epilepsies, 2nd edn. Raven Press Ltd, NY, pp 609–621 Engel J Jr, Van Ness PC, Rasmussen TB (1993) Outcome with respect to epileptic seizures. In: J Engel Jr (ed) Surgical treatment of the epilepsies, 2nd edn. Raven Press Ltd, NY, pp 609–621
17.
Zurück zum Zitat Fauser S, Huppertz HJ, Bast T et al (2006) Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain 129:1907–1916PubMedCrossRef Fauser S, Huppertz HJ, Bast T et al (2006) Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain 129:1907–1916PubMedCrossRef
18.
Zurück zum Zitat Finardi A, Gardoni F, Bassanini S et al (2006) NMDA receptor composition differs among anatomically diverse malformations of cortical development. J Neuropathol Exp Neurol 65:883–893PubMedCrossRef Finardi A, Gardoni F, Bassanini S et al (2006) NMDA receptor composition differs among anatomically diverse malformations of cortical development. J Neuropathol Exp Neurol 65:883–893PubMedCrossRef
19.
Zurück zum Zitat Garbelli R, Munari C, De Biasi S et al (1999) Taylor’s cortical dysplasia: a confocal and ultrastructural immunohistochemical study. Brain Pathol 9:445–461PubMedCrossRef Garbelli R, Munari C, De Biasi S et al (1999) Taylor’s cortical dysplasia: a confocal and ultrastructural immunohistochemical study. Brain Pathol 9:445–461PubMedCrossRef
20.
Zurück zum Zitat Gardoni F, Mauceri D, Malinverno M et al (2009) Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression. J Neurosci 29:669–677PubMedCrossRef Gardoni F, Mauceri D, Malinverno M et al (2009) Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression. J Neurosci 29:669–677PubMedCrossRef
21.
Zurück zum Zitat Glaser JR, Glaser EM (1990) Neuron imaging with Neurolucida—a PC-based system for image combining microscopy. Comput Med Imaging Graph 14:307–317PubMedCrossRef Glaser JR, Glaser EM (1990) Neuron imaging with Neurolucida—a PC-based system for image combining microscopy. Comput Med Imaging Graph 14:307–317PubMedCrossRef
22.
Zurück zum Zitat Hardiman O, Burke T, Phillips J et al (1998) Microdysgenesis in resected temporal neocortex: incidence and clinical significance in focal epilepsy. Neurology 38:1041–1047CrossRef Hardiman O, Burke T, Phillips J et al (1998) Microdysgenesis in resected temporal neocortex: incidence and clinical significance in focal epilepsy. Neurology 38:1041–1047CrossRef
23.
Zurück zum Zitat Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11:682–696PubMedCrossRef Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11:682–696PubMedCrossRef
24.
Zurück zum Zitat Hardingham GE, Fukunaga Y, Bading H (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosi 5:405–414 Hardingham GE, Fukunaga Y, Bading H (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosi 5:405–414
25.
Zurück zum Zitat Hur EE, Zaborszky L (2005) Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: a combined retrograde tracing in situ hybridization study. J Comp Neurol 483:351–373PubMedCrossRef Hur EE, Zaborszky L (2005) Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: a combined retrograde tracing in situ hybridization study. J Comp Neurol 483:351–373PubMedCrossRef
26.
Zurück zum Zitat Kim E, Sheng M (2004) PDZ domain proteins of synapses. Nat Rev Neurosi 5:771–781CrossRef Kim E, Sheng M (2004) PDZ domain proteins of synapses. Nat Rev Neurosi 5:771–781CrossRef
27.
Zurück zum Zitat Lamparello P, Baybis M, Pollard J et al (2007) Developmental lineage of cell types in cortical dysplasia with balloon cells. Brain 130:2267–2276PubMedCrossRef Lamparello P, Baybis M, Pollard J et al (2007) Developmental lineage of cell types in cortical dysplasia with balloon cells. Brain 130:2267–2276PubMedCrossRef
28.
Zurück zum Zitat Leiphart JW, Peacock WJ, Mathern GW (2001) Lobar and multilobar resections for medically intractable pediatric epilepsy. Pediatr Neurosurg 34:311–318PubMedCrossRef Leiphart JW, Peacock WJ, Mathern GW (2001) Lobar and multilobar resections for medically intractable pediatric epilepsy. Pediatr Neurosurg 34:311–318PubMedCrossRef
29.
Zurück zum Zitat Lerner JT, Salamon N, Hauptman JS et al (2009) Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 50:1310–1335PubMedCrossRef Lerner JT, Salamon N, Hauptman JS et al (2009) Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 50:1310–1335PubMedCrossRef
30.
Zurück zum Zitat Liou AK, Clark RS, Henshall DC, Yin XM, Chen J (2003) To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol 69:103–142PubMedCrossRef Liou AK, Clark RS, Henshall DC, Yin XM, Chen J (2003) To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol 69:103–142PubMedCrossRef
31.
Zurück zum Zitat Mischel PS, Nguyen LP, Vinters HV (1995) Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 54:137–153PubMedCrossRef Mischel PS, Nguyen LP, Vinters HV (1995) Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 54:137–153PubMedCrossRef
32.
Zurück zum Zitat Möddel G, Jacobson B, Ying Z et al (2005) NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia. Brain Res 1046:10–23PubMedCrossRef Möddel G, Jacobson B, Ying Z et al (2005) NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia. Brain Res 1046:10–23PubMedCrossRef
33.
Zurück zum Zitat Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529–540PubMedCrossRef Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529–540PubMedCrossRef
34.
Zurück zum Zitat Mühlebner A, Coras R, Kobow K et al (2012) Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol 123:259–272PubMedCrossRef Mühlebner A, Coras R, Kobow K et al (2012) Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol 123:259–272PubMedCrossRef
35.
Zurück zum Zitat Najm IM, Ying Z, Babb T et al (2000) Epileptogenicity correlated with increased N-Methyl-D-Aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 41:971–976PubMedCrossRef Najm IM, Ying Z, Babb T et al (2000) Epileptogenicity correlated with increased N-Methyl-D-Aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 41:971–976PubMedCrossRef
36.
Zurück zum Zitat Nakamura K, Hioki H, Fujiyama F, Kaneko T (2005) Postnatal changes of vesicular glutamate transporter (VGluT)1 and VGluT2 immunoreactivities and their colocalization in the mouse forebrain. J Comp Neurol. 492:263–288PubMedCrossRef Nakamura K, Hioki H, Fujiyama F, Kaneko T (2005) Postnatal changes of vesicular glutamate transporter (VGluT)1 and VGluT2 immunoreactivities and their colocalization in the mouse forebrain. J Comp Neurol. 492:263–288PubMedCrossRef
37.
Zurück zum Zitat Orlova KA, Tsai V, Baybis M et al (2010) Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias. J Neuropathol Exp Neurol 69:850–863PubMedCrossRef Orlova KA, Tsai V, Baybis M et al (2010) Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias. J Neuropathol Exp Neurol 69:850–863PubMedCrossRef
38.
Zurück zum Zitat Palmini A, Gambardella A, Andermann F et al (1995) Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 37:476–487PubMedCrossRef Palmini A, Gambardella A, Andermann F et al (1995) Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 37:476–487PubMedCrossRef
39.
Zurück zum Zitat Palmini A, Najm I, Avanzini G et al (2004) Terminology and classification of the cortical dysplasias. Neurology 62:S2–S8PubMedCrossRef Palmini A, Najm I, Avanzini G et al (2004) Terminology and classification of the cortical dysplasias. Neurology 62:S2–S8PubMedCrossRef
40.
Zurück zum Zitat Regalado MP, Terry-Lorenzo RT, Waites CL, Garner CC, Malenka RC (2006) Transsynaptic signaling by postsynaptic synapse-associated protein 97. J Neurosci 26:2343–2357PubMedCrossRef Regalado MP, Terry-Lorenzo RT, Waites CL, Garner CC, Malenka RC (2006) Transsynaptic signaling by postsynaptic synapse-associated protein 97. J Neurosci 26:2343–2357PubMedCrossRef
41.
Zurück zum Zitat Reuver SM, Garner CC (1998) E-cadherin mediated cell adhesion recruits SAP97 into the cortical cytoskeleton. J Cell Sci 111:1071–1080PubMed Reuver SM, Garner CC (1998) E-cadherin mediated cell adhesion recruits SAP97 into the cortical cytoskeleton. J Cell Sci 111:1071–1080PubMed
42.
Zurück zum Zitat Sattler R, Xiong Z, Lu WY, Hafner M, MacDonald JF, Tymianski M (1999) Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284:1845–1848PubMedCrossRef Sattler R, Xiong Z, Lu WY, Hafner M, MacDonald JF, Tymianski M (1999) Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284:1845–1848PubMedCrossRef
43.
Zurück zum Zitat Spreafico R, Battaglia G, Arcelli P et al (1998) Cortical dysplasia: an immunocytochemical study of three patients. Neurology 50:27–36PubMedCrossRef Spreafico R, Battaglia G, Arcelli P et al (1998) Cortical dysplasia: an immunocytochemical study of three patients. Neurology 50:27–36PubMedCrossRef
44.
Zurück zum Zitat Tassi L, Colombo N, Garbelli R et al (2002) Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 125:1719–1732PubMedCrossRef Tassi L, Colombo N, Garbelli R et al (2002) Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 125:1719–1732PubMedCrossRef
45.
Zurück zum Zitat Tassi L, Pasquier B, Minotti L et al (2001) Cortical dysplasia: electroclinical, imaging, and neuropathologic study of 13 patients. Epilepsia 42:1112–1123PubMedCrossRef Tassi L, Pasquier B, Minotti L et al (2001) Cortical dysplasia: electroclinical, imaging, and neuropathologic study of 13 patients. Epilepsia 42:1112–1123PubMedCrossRef
46.
Zurück zum Zitat Taylor DC, Falconer MA, Bruton CJ, Corsellis JA (1971) Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 34:369–387PubMedCrossRef Taylor DC, Falconer MA, Bruton CJ, Corsellis JA (1971) Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 34:369–387PubMedCrossRef
47.
Zurück zum Zitat Thom M, Martinian L, Sen A, Cross JH, Harding BN, Sisodiya SM (2005) Cortical neuronal densities and lamination in focal cortical dysplasia. Acta Neuropathol 110:383–392PubMedCrossRef Thom M, Martinian L, Sen A, Cross JH, Harding BN, Sisodiya SM (2005) Cortical neuronal densities and lamination in focal cortical dysplasia. Acta Neuropathol 110:383–392PubMedCrossRef
48.
Zurück zum Zitat van der Hel WS, Verlinde SA, Meijer DH et al (2009) Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy. Epilepsia 50:1717–1728PubMedCrossRef van der Hel WS, Verlinde SA, Meijer DH et al (2009) Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy. Epilepsia 50:1717–1728PubMedCrossRef
49.
Zurück zum Zitat Vercelli A, Mereuta OM, Garbossa D et al (2008) Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 31:395–405PubMedCrossRef Vercelli A, Mereuta OM, Garbossa D et al (2008) Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 31:395–405PubMedCrossRef
50.
Zurück zum Zitat West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482–497PubMedCrossRef West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482–497PubMedCrossRef
51.
Zurück zum Zitat Ying Z, Babb TL, Comair YG, Bingaman W, Bushey M, Touhalisky K (1998) Induced expression of NMDAR2 proteins and differential expression of NMDAR1 splice variants in dysplastic neurons of human epileptic neocortex. J Neuropathol Exp Neurol 57:47–62PubMedCrossRef Ying Z, Babb TL, Comair YG, Bingaman W, Bushey M, Touhalisky K (1998) Induced expression of NMDAR2 proteins and differential expression of NMDAR1 splice variants in dysplastic neurons of human epileptic neocortex. J Neuropathol Exp Neurol 57:47–62PubMedCrossRef
52.
Zurück zum Zitat Ying Z, Babb TL, Mikuni N, Najm I, Drazba J, Bingaman W (1999) Selective coexpression of NMDAR2A/B and NMDAR1 subunit proteins in dysplastic neurons of human epileptic cortex. Exp Neurol 159:409–418PubMedCrossRef Ying Z, Babb TL, Mikuni N, Najm I, Drazba J, Bingaman W (1999) Selective coexpression of NMDAR2A/B and NMDAR1 subunit proteins in dysplastic neurons of human epileptic cortex. Exp Neurol 159:409–418PubMedCrossRef
53.
Zurück zum Zitat Ying Z, Bingaman W, Najm IM (2004) Increased numbers of coassembled PSD-95 to NMDA-receptor subunits NR2B and NR1 in human epileptic cortical dysplasia. Epilepsia 45:314–321PubMedCrossRef Ying Z, Bingaman W, Najm IM (2004) Increased numbers of coassembled PSD-95 to NMDA-receptor subunits NR2B and NR1 in human epileptic cortical dysplasia. Epilepsia 45:314–321PubMedCrossRef
Metadaten
Titel
Long-duration epilepsy affects cell morphology and glutamatergic synapses in type IIB focal cortical dysplasia
verfasst von
Adele Finardi
Francesca Colciaghi
Laura Castana
Denise Locatelli
Carlo Efisio Marras
Paola Nobili
Maddalena Fratelli
Manuela Adele Bramerio
Giorgio LoRusso
Giorgio Stefano Battaglia
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Acta Neuropathologica / Ausgabe 2/2013
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-013-1143-4

Weitere Artikel der Ausgabe 2/2013

Acta Neuropathologica 2/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.